0 0

Cited 0 times in

Cited 0 times in

Cluster analysis of diet and lifestyle factors associated with metabolic dysfunction-associated steatotic liver disease: findings from Korean Genome and Epidemiology Study

DC Field Value Language
dc.contributor.authorLee, Jong Hee-
dc.contributor.authorRyu, Ha-Eun-
dc.contributor.authorHan, Taehwa-
dc.contributor.authorPark, Byoungjin-
dc.contributor.authorHeo, Seok-Jae-
dc.contributor.authorKwon, Yu-Jin-
dc.date.accessioned2025-11-14T02:01:37Z-
dc.date.available2025-11-14T02:01:37Z-
dc.date.created2025-07-29-
dc.date.issued2025-06-
dc.identifier.issn1355-008X-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/208814-
dc.description.abstractPurpose As the global prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) continues to increase, its early detection is crucial. We investigated the combined effects of various factors on MASLD development to enhance the understanding of individuals at high risk of MASLD. Methods A total of 4670 participants from the Korean Genome and Epidemiology Study were included. Cluster analysis and Cox proportional hazards regression were conducted to identify distinct risk factor clusters and evaluate their association with MASLD incidence. Results Four clusters were identified based on lifestyle characteristics: Cluster 1 (LA)-low activity, Cluster 2 (HPF)-lowest carbohydrate intake with high protein and fat intake, Cluster 3 (HC)-highest carbohydrate intake with low protein and fat intake, and Cluster 4 (ASC)-highest alcohol consumption and smoking levels. Cluster 4 (ASC) exhibited the highest cumulative incidence of MASLD, followed by Cluster 3 (HC). Compared to Clusters 1, 2, and 3, Cluster 4 (ASC) had significantly higher hazard ratios (HRs) for MASLD incidence (HR: 1.35 [95% confidence interval {CI}: 1.19-1.53]; p < 0.001, HR: 1.31 [95% CI: 1.14-1.50]; p < 0.001, and HR: 1.22 [95% CI: 1.07-1.38]; p = 0.002, respectively). Conclusion Clusters exhibiting various risk factor phenotypes were identified, and smoking, alcohol consumption, and carbohydrate intake were significantly associated with a higher risk of MASLD. Our findings support the importance of early screening and personalized approaches for individuals at high risk of MASLD.-
dc.languageEnglish-
dc.publisherHumana Press-
dc.relation.isPartOfENDOCRINE-
dc.relation.isPartOfENDOCRINE-
dc.subject.MESHAdult-
dc.subject.MESHAged-
dc.subject.MESHAlcohol Drinking / epidemiology-
dc.subject.MESHCluster Analysis-
dc.subject.MESHDiet* / statistics & numerical data-
dc.subject.MESHFatty Liver* / epidemiology-
dc.subject.MESHFatty Liver* / etiology-
dc.subject.MESHFemale-
dc.subject.MESHHumans-
dc.subject.MESHIncidence-
dc.subject.MESHLife Style*-
dc.subject.MESHMale-
dc.subject.MESHMiddle Aged-
dc.subject.MESHRepublic of Korea / epidemiology-
dc.subject.MESHRisk Factors-
dc.titleCluster analysis of diet and lifestyle factors associated with metabolic dysfunction-associated steatotic liver disease: findings from Korean Genome and Epidemiology Study-
dc.typeArticle-
dc.contributor.googleauthorLee, Jong Hee-
dc.contributor.googleauthorRyu, Ha-Eun-
dc.contributor.googleauthorHan, Taehwa-
dc.contributor.googleauthorPark, Byoungjin-
dc.contributor.googleauthorHeo, Seok-Jae-
dc.contributor.googleauthorKwon, Yu-Jin-
dc.identifier.doi10.1007/s12020-025-04200-3-
dc.relation.journalcodeJ00768-
dc.identifier.eissn1559-0100-
dc.identifier.pmid40025306-
dc.identifier.urlhttps://link.springer.com/article/10.1007/s12020-025-04200-3-
dc.subject.keywordMetabolic dysfunction-associated steatotic liver disease-
dc.subject.keywordCluster analysis-
dc.subject.keywordDiet-
dc.subject.keywordLifestyle-
dc.contributor.affiliatedAuthorLee, Jong Hee-
dc.contributor.affiliatedAuthorRyu, Ha-Eun-
dc.contributor.affiliatedAuthorHan, Taehwa-
dc.contributor.affiliatedAuthorPark, Byoungjin-
dc.contributor.affiliatedAuthorHeo, Seok-Jae-
dc.contributor.affiliatedAuthorKwon, Yu-Jin-
dc.identifier.scopusid2-s2.0-85219037425-
dc.identifier.wosid001435293700001-
dc.citation.volume88-
dc.citation.number3-
dc.citation.startPage717-
dc.citation.endPage726-
dc.identifier.bibliographicCitationENDOCRINE, Vol.88(3) : 717-726, 2025-06-
dc.identifier.rimsid88215-
dc.type.rimsART-
dc.description.journalClass1-
dc.description.journalClass1-
dc.subject.keywordAuthorMetabolic dysfunction-associated steatotic liver disease-
dc.subject.keywordAuthorCluster analysis-
dc.subject.keywordAuthorDiet-
dc.subject.keywordAuthorLifestyle-
dc.subject.keywordPlusSTATEMENT-
dc.subject.keywordPlusPROTEIN-
dc.subject.keywordPlusRISK-
dc.subject.keywordPlusFAT-
dc.type.docTypeArticle-
dc.description.isOpenAccessN-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.relation.journalWebOfScienceCategoryEndocrinology & Metabolism-
dc.relation.journalResearchAreaEndocrinology & Metabolism-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Family Medicine (가정의학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Yonsei Biomedical Research Center (연세의생명연구원) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Biomedical Systems Informatics (의생명시스템정보학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.